BioMap Unveils 11 AI Life-Science Deals at Hong Kong Summit
BioMap announced 11 collaborations at the Hong Kong summit, spanning breast-cancer modeling, TCM research, crop breeding and a Singapore AI bio-computing center.
Topic
Life Sciences
Topic
Life Sciences
Cambridge Tech and Life Sciences Firms Raise Nearly $2.5 Billion in 12 Months
Cambridge tech and life sciences firms raised almost $2.5bn in 12 months, with CuspAI, Cambridge Aerospace, CMR Surgical and Cell…
Anthropic Bets Big on Life Sciences Ahead of IPO
Anthropic's S-1 filing pitches drug discovery as its next business: a $400M biotech acquisition, 50,000 Claude seats at Lilly, an…
US Biotechs Capture $37.2B of Global $54.5B VC Funding Since 2025
U.S. biopharma firms raised $37.2B since 2025 — 68% of the world's $54.5B total — with the Bay Area and Boston absorbing 62% of A…
Greater Baltimore startups raised $559.8 million in 2025, but fewer dollars
Greater Baltimore startups closed 77 venture deals worth $559.8 million in 2025 — more rounds, fewer dollars — as UpSurge tracks…
US Proposes Investment Curbs on Chinese Biotech Firms
Treasury proposes adding biotech to sensitive-technology investment limits, hitting Chinese biotech shares, though licensing deal…
SOAR Bio Lands $600,000 to Scale DC's First Life Sciences Venture Studio
SOAR Bio has won a $600,000 DC Technology Ecosystem Fund award to expand the District's first life sciences venture studio, BioBu…
TCGX Picks Migraine Biotech TriGemX for SPAC Route to Public Markets
Investment firm TCGX has selected TriGemX, a migraine-focused biotech, to take public via a SPAC merger, Fierce Biotech reports.
OrbiMed Raises $3 Billion to Back Global Life Science Players
OrbiMed has raised $3 billion to back life science players worldwide, adding major dry powder to healthcare investing and widenin…
OrbiMed Raises Two New Life Sciences Funds Totaling $3B
OrbiMed has raised two new life sciences funds totaling $3 billion, BioSpace reports, with one vehicle targeting Asia's biotech a…
OrbiMed Closes $1.9B Life Sciences Fund in $3B Double Close
OrbiMed raised a $1.9 billion life sciences fund as part of a double close totaling roughly $3 billion, Dealroom reports — one of…